Deals in brief: Bioactivx raises pre-Series A funding, SMBC and Singtel Innov8 back fileAI, latest China investments, and more

The KrAsia report details several significant funding rounds across Asia, with a notable focus on Singaporean and Indonesian startups. Bioactivx, a Singapore-based wound care technology firm, raised USD 3 million, highlighting continued investor interest in medical innovations from the city-state. Its Bioactiv Matrix product, a synthetic skin substitute, could address critical needs in diverse settings, including military and remote healthcare, due to its lack of cold chain requirements. This suggests a strategic play for market segments often overlooked by conventional medical device manufacturers. Separately, Indonesia's Ajaib secured a substantial USD 270 million Series C round from Japan's SBI Holdings, pushing its total funding past USD 500 million. This investment values Ajaib at approximately USD 1.35 billion, underscoring the robust growth and investor confidence in Indonesia's fintech sector, particularly in online investment platforms targeting younger retail investors. The partnership with SBI Holdings could further accelerate Ajaib's expansion and product diversification, leveraging SBI's expertise in traditional financial services and digital assets. The move also reflects Japan's strategic interest in Southeast Asian digital economies.